OBI Pharma, Inc. (TPEX: 4174)
Taiwan
· Delayed Price · Currency is TWD 76.30
+0.80 (1.06%)
Sep 11, 2024, 10:00 AM CST
OBI Pharma Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 17,308 | 15,910 | 15,831 | 22,680 | 26,213 | 24,833 | Upgrade
|
| Market Cap Growth | -37.43% | 0.50% | -30.20% | -13.48% | 5.56% | -8.35% | Upgrade
|
| Enterprise Value | 17,057 | 14,396 | 12,411 | 21,039 | 22,895 | 20,239 | Upgrade
|
| Last Close Price | 75.50 | 69.40 | 69.10 | 112.86 | 137.61 | 130.68 | Upgrade
|
| PE Ratio | - | -15.19 | -9.51 | -14.67 | -19.83 | -17.81 | Upgrade
|
| PS Ratio | 298.08 | 382.92 | 3360.52 | 1208.19 | 186.06 | 4445.58 | Upgrade
|
| PB Ratio | 6.03 | 3.21 | 2.58 | 5.86 | 5.42 | 4.19 | Upgrade
|
| P/FCF Ratio | -6.98 | -9.07 | -8.45 | -17.37 | -14.63 | -20.92 | Upgrade
|
| P/OCF Ratio | -7.47 | -9.62 | -9.77 | -21.31 | -16.29 | -22.23 | Upgrade
|
| EV/Sales Ratio | 293.85 | 346.49 | 2634.54 | 1120.77 | 162.51 | 3623.12 | Upgrade
|
| EV/EBITDA Ratio | -6.41 | -7.53 | -6.41 | -13.50 | -17.63 | -14.33 | Upgrade
|
| EV/EBIT Ratio | -5.96 | -6.89 | -5.85 | -12.26 | -15.62 | -12.83 | Upgrade
|
| EV/FCF Ratio | -8.54 | -8.20 | -6.62 | -16.11 | -12.78 | -17.05 | Upgrade
|
| Debt / Equity Ratio | 0.13 | 0.11 | 0.05 | 0.08 | 0.05 | 0.05 | Upgrade
|
| Debt / FCF Ratio | -0.25 | -0.31 | -0.16 | -0.22 | -0.14 | -0.23 | Upgrade
|
| Asset Turnover | 0.01 | 0.01 | 0.00 | 0.00 | 0.02 | 0.00 | Upgrade
|
| Inventory Turnover | 4.45 | 4.80 | 2.84 | 5.24 | 1.12 | - | Upgrade
|
| Quick Ratio | 13.87 | 17.73 | 21.71 | 8.18 | 15.05 | 23.38 | Upgrade
|
| Current Ratio | 15.84 | 19.92 | 22.76 | 8.72 | 15.67 | 23.97 | Upgrade
|
| Return on Equity (ROE) | -46.55% | -22.83% | -37.96% | -39.45% | -27.69% | -32.99% | Upgrade
|
| Return on Assets (ROA) | -25.39% | -21.35% | -23.86% | -21.83% | -15.49% | -17.61% | Upgrade
|
| Return on Capital (ROIC) | -25.70% | -21.90% | -25.05% | -23.20% | -16.24% | -18.36% | Upgrade
|
| Earnings Yield | -12.46% | -6.58% | -10.19% | -6.75% | -5.26% | -5.67% | Upgrade
|
| FCF Yield | -11.55% | -11.03% | -11.84% | -5.76% | -6.84% | -4.78% | Upgrade
|
| Buyback Yield / Dilution | -0.02% | -3.12% | -11.65% | -0.18% | -3.56% | -10.80% | Upgrade
|
| Total Shareholder Return | -0.02% | -3.12% | -11.65% | -0.18% | -3.56% | -10.80% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.